Distribution of Immune Cells and Their Subtypes in Peripheral Blood of Gout

Imagery as Biomarker of Gout

NCT05434858 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Immune Molecular and Inflammatory Cytokines Dysfunction Analysis in Gout Patients With Different Urate Levels

NCT02060552 ·Status: COMPLETED ·Phase: PHASE4

A Phase Ib/II Study of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection in Chinese Participants With Acute Gout

NCT05588908 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

NLRP3 Inflammasome Activation Among Patients During Acute Gout Flares

NCT05744297 ·Status: UNKNOWN

A Controlled Study of Uric Acid on the Progression of IgA Nephropathy

NCT00793585 ·Status: COMPLETED ·Phase: NA

A Study of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection in Chinese Participants With Acute Gout

NCT06169891 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Safety and Efficacy of Genakumab for Injection in Patients With Gout Flare

NCT05936268 ·Status: COMPLETED ·Phase: PHASE2

Clinical Study of Genakumab for Injection in Patients With Acute Gout

NCT05328531 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study of Pegloticase in Participants With Uncontrolled Gout Who Have Had a Kidney Transplant

NCT04087720 ·Status: COMPLETED ·Phase: PHASE4

A Study of the Efficacy of Genakumab in Prevention of Acute Flares in Gout Patients Initiating Urate-lowering TherapyUrate-lowering (GenSci048-202)

NCT05936281 ·Status: COMPLETED ·Phase: PHASE2

MRI and Ultrasound Findings in Patients With Gout and Normal Plain Radiographs

NCT00584311 ·Status: COMPLETED ·Phase: NA

Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ Fusion Protein in the Treatment of Acute Gout

NCT05925166 ·Status: COMPLETED ·Phase: NA

An Assessment of Chronic Synovial-Based Inflammation and Its Role With Serum Urate Levels.

NCT01112982 ·Status: COMPLETED ·Phase: PHASE4

A Phase Ib Clinical Trial of Peguricase for Injection With Methotrexate in Patients With Uncontrolled Gout.

NCT06298071 ·Status: RECRUITING ·Phase: PHASE1

Gout Self-Monitoring Aiming to Reach Target

NCT03274063 ·Status: COMPLETED ·Phase: NA

Study of URC102 to Assess the Safety and Efficacy in Gout Patients

NCT02557126 ·Status: COMPLETED ·Phase: PHASE2

Safety & Efficacy of Canakinumab (ACZ885) in Patients With Frequent Flares for Whom Nonsterodial Anti-Inflammatory Drug (NSAIDs) and/ or Colchicine Are Contraindicated, Not Tolerated or Ineffective

NCT01362608 ·Status: TERMINATED ·Phase: PHASE3

Musculoskeletal Ultrasound in Asymptomatic Hyperuricemia

NCT02502565 ·Status: UNKNOWN

Pegloticase and Methotrexate Co-administered in Participants With Uncontrolled Gout Who Previously Failed Pegloticase Monotherapy

NCT04772313 ·Status: COMPLETED ·Phase: PHASE4

The Influence of Antiphospholipid Antibodies on the Relationship Between Hyperurecemia, Gout and Metabolic Syndrome

NCT01818505 ·Status: UNKNOWN

Study of FYU-981 in Hyperuricemia With or Without Gout

NCT02344862 ·Status: COMPLETED ·Phase: PHASE2

Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients

NCT05586958 ·Status: COMPLETED ·Phase: PHASE3

Open-Label Extension Study for Patients Who Completed a Phase 3 Double-blind Study of PEG-uricase for Symptomatic Gout

NCT01356498 ·Status: COMPLETED ·Phase: PHASE3

Improving Gout Care After an ED Visit

NCT06534554 ·Status: RECRUITING ·Phase: NA

A Study to Evaluate Efficacy of Dotinurad and Febuxostat for the Treatment of Participants With Gout

NCT05007392 ·Status: COMPLETED ·Phase: PHASE3